[HTML][HTML] Short-term safety of COVID-19 mRNA vaccines with respect to all-cause mortality in the older population in Norway
PLD Ruiz, N Gunnes, JM Gran, Ø Karlstad, R Selmer… - Vaccine, 2023 - Elsevier
Background There have been concerns about COVID-19 vaccination safety among frail
older individuals. We investigated the relationship between COVID-19 mRNA vaccination …
older individuals. We investigated the relationship between COVID-19 mRNA vaccination …
Effectiveness of a fourth dose of mRNA COVID-19 vaccine against all-cause mortality in long-term care facility residents and in the oldest old: A nationwide …
P Nordström, M Ballin, A Nordström - The Lancet Regional Health …, 2022 - thelancet.com
Background The effect of a fourth dose of COVID-19 vaccine on the risk of death in the
oldest and frailest individuals is unknown. Methods Two matched cohorts were formed using …
oldest and frailest individuals is unknown. Methods Two matched cohorts were formed using …
Effectiveness of vaccination against SARS-CoV-2 infection and Covid-19 hospitalisation among Finnish elderly and chronically ill—An interim analysis of a nationwide …
U Baum, E Poukka, AA Palmu, H Salo, TO Lehtonen… - PLoS …, 2021 - journals.plos.org
Background In Finland, both mRNA and adenovirus vector (AdV) Covid-19 vaccines have
been used after the vaccination campaign started on December 27, 2020. Vaccination of the …
been used after the vaccination campaign started on December 27, 2020. Vaccination of the …
Effectiveness and durability of a second COVID-19 booster against severe outcomes among older people in Norway: a population-based cohort study comparing …
M Stecher, AB Kristoffersen, K Lie… - International Journal …, 2023 - academic.oup.com
Background Evidence on the durability of the protection of a fourth dose of a monovalent or
bivalent messenger ribonucleic acid (mRNA) vaccine against coronavirus disease 2019 …
bivalent messenger ribonucleic acid (mRNA) vaccine against coronavirus disease 2019 …
Reduced risk of severe COVID-19 in more than 1.4 million elderly people aged 75 years and older vaccinated with mRNA-based vaccines
J Botton, R Dray-Spira, B Baricault, J Drouin… - Vaccine, 2022 - Elsevier
Randomized clinical trials have shown mRNA-based vaccines to be 92–95% effective to
prevent COVID-19 in adults. We aimed to estimate the impact of vaccination on the risk of …
prevent COVID-19 in adults. We aimed to estimate the impact of vaccination on the risk of …
Determinants of humoral and cellular immune responses to three doses of mRNA SARS-CoV-2 vaccines in older adults: A longitudinal cohort study
A Ravussin, AH Robertson, AS Wolf, K Blix… - The Lancet Healthy …, 2023 - thelancet.com
Background Older age is associated with poorer outcomes to COVID-19 infection. The
Norwegian Institute of Public Health established a longitudinal cohort of adults aged 65–80 …
Norwegian Institute of Public Health established a longitudinal cohort of adults aged 65–80 …
mRNA vaccine effectiveness against COVID-19-related hospitalisations and deaths in older adults: a cohort study based on data linkage of national health registries in …
B Nunes, AP Rodrigues, I Kislaya, C Cruz… - …, 2021 - eurosurveillance.org
Through deterministic data linkage of health registries, mRNA vaccine effectiveness (VE)
against COVID-19-related hospitalisations and deaths was measured in 1,880,351 older …
against COVID-19-related hospitalisations and deaths was measured in 1,880,351 older …
Effectiveness of Covid-19 vaccination against risk of symptomatic infection, hospitalization, and death up to 9 months: a Swedish total-population cohort study
P Nordström, M Ballin, A Nordström - Hospitalization, and Death …, 2021 - papers.ssrn.com
Background: Whether vaccine effectiveness against Coronavirus disease 2019 (Covid-19)
lasts longer than 6 months is unclear. Methods: A retrospective cohort study was conducted …
lasts longer than 6 months is unclear. Methods: A retrospective cohort study was conducted …
[HTML][HTML] COVID-19 vaccination uptake strongly predicts averted deaths of older people across Europe
Background: Nationwide COVID-19 (coronavirus disease 2019) vaccination campaigns
have been effective to avert as many as 51% deaths in people aged≥ 60 years in the …
have been effective to avert as many as 51% deaths in people aged≥ 60 years in the …
Differences in characteristics and outcomes of older patients hospitalized for COVID-19 after introduction of vaccination
RAL Smits, BFM van Raaij, S Trompet… - European Geriatric …, 2024 - Springer
Purpose The aim of the present study was to investigate characteristics and outcomes in
vaccinated and unvaccinated older patients hospitalized for COVID-19 infection. Methods A …
vaccinated and unvaccinated older patients hospitalized for COVID-19 infection. Methods A …